Image

Association Between Human Immunodeficiency Virus (HIV) Infection and Male Hypogonadism

Association Between Human Immunodeficiency Virus (HIV) Infection and Male Hypogonadism

Recruiting
20 years and older
Male
Phase N/A

Powered by AI

Overview

Cross-sectional study investigating the prevalence of hypogonadism in HIV-infected MSM population

Description

In this study, we conduct a cross-sectional study investigating the prevalence of hypogonadism in HIV-infected MSM population. Age-matched non-HIV infected MSM group will be used as comparison group. We will also determine the risk factors associated with male hypogonadism (age, duration of HIV infection, comorbidities, BMI, ART use). Correlation will be made between serum testosterone levels and sexual function, vitality, exercise capacity, mood, and bone mineral density.

Eligibility

Inclusion Criteria:

  • HIV-infected men who have sex with men
  • HIV non-infected men

Exclusion Criteria:

  • Use of testosterone supplement, anabolic steroid in the past one year.
  • History of pituitary , adrenal or gonad diseases
  • History of pituitary surgery or radiation therapy
  • History of systemic chemotherapy
  • Active opportunistic infection under treatment
  • Cancer
  • Severe hepatic, renal or cardiac impairment

Study details
    Hypogonadism; Ovarian

NCT04760574

National Taiwan University Hospital

28 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.